Rankings
▼
Calendar
COLL FY 2013 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
FY 2013 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$16M
Net Income
-$16M
EPS (Diluted)
$-2.17
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$62,000
Balance Sheet
Total Assets
$9M
Total Liabilities
$3M
Stockholders' Equity
$6M
Cash & Equivalents
$8M
← FY 2014
All Quarters
